Edwards Lifesciences Corp

NYSE:EWHealthcareCBOE:SPESGSTOXX:EDD24BP

$87.22+0.72%At closeAt close · Tue 20 Oct · ≈ AED 320.32 · Market cap $50.27B · Next earnings Thu 29 Oct · Extended $87.01 −0.24%

USD billions	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	TTM	YoY
Revenue	4.4	5.2	5.4	5.0	5.4	6.1	6.5	+7.3%
Cost of revenue	1.1	1.2	1.2	1.0	1.1	1.3	1.4	+8.5%
Gross profit	3.3	4.0	4.2	4.0	4.3	4.7	5.1	+7.0%
Research & development	0.8	0.9	0.9	1.0	1.1	1.1	1.1	+1.1%
Selling, general & administrative	1.2	1.5	1.6	1.6	1.8	2.1	—	—
Selling & marketing	0.0	0.0	0.0	0.0	0.0	0.0	—	—
Operating expenses	2.0	2.4	2.5	2.5	2.9	3.1	—	—
Operating income	1.3	1.6	1.7	1.4	1.4	1.6	1.5	−9.2%
Interest expense	0.0	0.0	0.0	0.0	0.0	0.0	—	—
Interest income	0.0	0.0	0.0	0.1	0.1	0.1	—	—
Other income / expense	(0.4)	0.1	0.1	(0.1)	0.2	(0.4)	—	—
Pre-tax income	0.9	1.7	1.8	1.4	1.5	1.3	1.4	+11.4%
Income tax	0.1	0.2	0.2	0.2	0.2	0.2	0.4	+102.4%
Net income	0.8	1.5	1.5	1.4	4.2	1.1	1.0	−6.4%
Discontinued operations	0.0	0.0	0.0	0.2	2.8	0.0	—	—
Other net income adjustments	0.0	0.0	0.0	0.0	0.0	0.0	—	—
EPS, basic (per share)	1.32	2.41	2.46	2.31	6.98	1.84	1.69	−8.1%
EPS, diluted (per share)	1.30	2.38	2.44	2.30	6.97	1.83	1.69	−7.6%
EBITDA	1.1	1.9	2.0	1.5	1.7	1.4	1.6	+11.6%
Depreciation & amortization	0.1	0.2	0.2	0.1	0.2	0.2	0.2	+5.7%
Weighted average shares (shares)	622,600,000	623,300,000	619,000,000	606,700,000	597,700,000	584,800,000	—	—
Weighted average diluted shares (shares)	631,900,000	631,200,000	624,200,000	609,400,000	599,300,000	585,800,000	—	—
Gross margin	74.9%	76.6%	78.3%	79.3%	79.5%	78.1%	77.9%	−0.2 pts
Operating margin	29.5%	30.8%	31.6%	28.5%	25.3%	27.0%	22.8%	−4.1 pts
Net margin	18.8%	28.7%	28.3%	28.0%	76.7%	17.7%	15.4%	−2.3 pts